An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population. Issue 1 (February 2015)

• Record Type: Journal Article
• Authors: Nathan, Hannah L.; de Greeff, Annemarie; Hezelgrave, Natasha L.; Chappell, Lucy C.; Shennan, Andrew H.
• Is Part Of: Blood pressure monitoring. Volume 20:Issue 1(2015)
• Publication Date: 2015-02
• Subjects: Blood pressure -- Measurement -- Periodicals; Blood Pressure Determination -- Periodicals; Blood Pressure Monitoring, Ambulatory -- Periodicals; Blood Pressure Monitors -- Periodicals; Hypertension -- Periodicals; 612.140287
• DOI: 10.1097/MBP.0000000000000086
• Languages: English
• ISSNs: 1359-5237

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Objectives</title> <p>To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting.</p> </sec> <sec> <title>Methods</title> <p>Prospective validation according to the British Hypertension Society protocol. A total of 45 pregnant women were recruited from Kimberley Hospital (South Africa), of whom 15 had pre-eclampsia.</p> </sec> <sec> <title>Results</title> <p>The Microlife 3AS1-2 device achieved an overall B/A grade in pregnancy (including pre-eclampsia), passing the British Hypertension Society protocol requirements and achieving the International Organization for Standardization standard with a mean difference and SD of −3.8±7.3 and −1.5±6.2 mmHg for systolic and diastolic pressures, respectively.</p> </sec> <sec> <title>Conclusion</title> <p>The Microlife 3AS1-2 device can be recommended for use in pregnancy, including pre-eclampsia. In addition, it fulfils the requirements stipulated by the WHO for an automated blood pressure device suitable for use in a low-resource setting. This makes it the ideal device for antenatal clinics and primary healthcare facilities in low-income and middle-income countries.</p> </sec> </abstract>